Doctor profile · Federal record

Dr. Aaron Pumerantz, D.O.

Rheumatology Physician (CMS: Rheumatology) · Toledo, OH

  • NPI 1407088438
  • Accepts Medicare
  • 17 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
4235 Secor RD
Toledo, OH 436234231
(419) 479-5860
fax (419) 479-3971
Additional location
3830 Woodley RD Ste B
Toledo, OH 436061177
(419) 473-9380
fax (419) 473-9515

Credentials & registration

NPPES · NUCC
NPI registered
August 2009 — 17 yrs on file
Profile last updated
January 9, 2025
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Ohio #34013141
Medicaid
OH #0293956

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407088438. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
80,863
Distinct HCPCS
10
Medicare allowed
$1,254,348
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 44,720 12 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 15,950 19 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 9,975 11 $42
J0897 Injection, denosumab, 1 mg 3,540 33 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,530 14 $33
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,296 124 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 685 353 $121
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 325 51 $59
96415 Administration of chemotherapy into vein, each additional hour 162 24 $26
J7050 Infusion, normal saline solution, 250 cc 137 29 $1

In context: peer comparison

Among 2 peers in Toledo Rheumatology Physician, average services per provider: 3,392. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,557
Transactions
99
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 42 $982.21
Janssen Biotech, INC. 11 $437.31
Amgen INC. 13 $255.60
AstraZeneca Pharmaceuticals Lp 7 $214.04
Novartis Pharmaceuticals Corporation 10 $157.37
Kiniksa Pharmaceuticals International, Plc 1 $124.56
HydroCision, INC. 1 $83.67
GlaxoSmithKline, LLC. 4 $81.91
E.R. Squibb & Sons, L.L.C. 4 $76.41
Pfizer INC. 1 $25.12
Alvogen INC 1 $22.73
Lilly USA, LLC 1 $22.27
Boehringer Ingelheim Pharmaceuticals, INC. 1 $20.93
Organon LLC 1 $20.02
Genentech USA, INC. 1 $17.26

By nature of payment

Food and Beverage
$2,557

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,828
Patients
735
Total drug cost
$572,349
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 438 157 $44,555
Prednisone Generic 370 185 $3,016
Methotrexate (Methotrexate Sodium) Brand 356 146 $20,044
Allopurinol Generic 107 35 $1,879
Methylprednisolone Generic 87 67 $1,229
Alendronate Sodium Generic 85 28 $1,072
Meloxicam Generic 75 41 $614
Leflunomide Generic 70 27 $7,497
Sulfasalazine Generic 64 23 $3,070
Folic Acid Generic 38 15 $184

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Aaron Pumerantz's medical specialty?
Dr. Aaron Pumerantz practices Rheumatology Physician in Toledo, OH.
Where does Dr. Aaron Pumerantz practice?
Dr. Aaron Pumerantz practices at 4235 Secor RD, Toledo, OH 436234231. Office phone: 4194795860.
What is Dr. Aaron Pumerantz's NPI?
Dr. Aaron Pumerantz's National Provider Identifier (NPI) is 1407088438, issued by NPPES.
Does Dr. Aaron Pumerantz accept Medicare assignment?
Yes. Dr. Aaron Pumerantz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aaron Pumerantz commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.